Arena Pharmaceuticals

Founded in 1997, Arena Pharmaceuticals is a United States biopharmaceutical subsidiary of Pfizer that developed potential therapies for immuno-inflammatory and cardiovascular diseases, including etrasimod. Pfizer completed the acquisition on March 11, 2022, and continues to list Arena as a subsidiary.